Bird & Bird advised Biomemory on its €17 million fundraising round

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol

News & Deals

More News & Deals
Deal Bird & Bird advises ThreatSpike on its $14 million Series A fundraise

Jun 09 2025

Read More
Deal Bird & Bird advises Nordic Unmanned Holding on strategic sale of AirRobot to Quantum Systems

Jun 03 2025

Read More
Deal Bird & Bird advises Signalbolaget Holding AB and founders on the divestment of all issued and outstanding shares

Jun 03 2025

Read More
Deal Bird & Bird advises Koskisen Corporation on strategic acquisition of Iisveden Metsä

Jun 02 2025

Read More
Deal Bird & Bird advises Emaldo on strategic acquisition of CheckWatt, cementing Nordic leadership in renewable energy

May 28 2025

Read More
Deal Bird & Bird advises Eulero Capital on the acquisition of DIEWE Wheels

May 27 2025

Read More